Virulence and Experimental Treatment of Trichoderma longibrachiatum, a Fungus Refractory to Treatment

Katihuska Paredes1, Javier Capilla2, Emilio Mayayo3

  • 1Unitat de Microbiologia, Facultat de Medicina i Ciències de la Salut, IISPV, Universitat Rovira i Virgili, Reus, Tarragona, Spain.

Insights

Trichoderma longibrachiatum showed low virulence in mice but high resistance to antifungal drugs. The highest fungal inoculum (1 × 10^7 CFU/animal) was lethal, primarily affecting the spleen and liver.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Emerging fungal infections pose a significant threat.
  • Trichoderma species are increasingly recognized for their clinical relevance.
  • Understanding the pathogenicity and drug resistance of Trichoderma longibrachiatum is crucial.

Purpose of the Study:

  • To evaluate the virulence of Trichoderma longibrachiatum in a murine model.
  • To assess the efficacy of common antifungal agents against this fungus.
  • To characterize the pathogenic potential and antifungal resistance profile of T. longibrachiatum.

Main Methods:

  • Murine model of infection with varying inocula of Trichoderma longibrachiatum.
  • Administration of amphotericin B deoxycholate, liposomal amphotericin B, voriconazole, and micafungin.
  • Monitoring of animal survival and assessment of affected organs (spleen and liver).

Main Results:

  • The highest inoculum (1 × 10^7 CFU/animal) resulted in 100% mortality by day 15 postinfection.
  • Spleen and liver were identified as the primary target organs for infection.
  • All tested antifungal drugs demonstrated very poor efficacy against the fungus.

Conclusions:

  • Trichoderma longibrachiatum exhibits low intrinsic virulence.
  • The fungus demonstrates significant resistance to established antifungal compounds.
  • This highlights the need for novel therapeutic strategies against T. longibrachiatum infections.

Related Concept Videos